Live Breaking News & Updates on Faye Feller

Stay updated with breaking news from Faye feller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Geron Co. (NASDAQ:GERN) EVP Sells $1,332,977.00 in Stock

Geron Co. (NASDAQ:GERN – Get Free Report) EVP Faye Feller sold 287,900 shares of Geron stock in a transaction on Monday, June 10th. The shares were sold at an average price of $4.63, for a total value of $1,332,977.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is […] ....

United States , Robertw Baird , Faye Feller , Stifel Nicolaus , Geron Co , Pathstone Family Office , Hermes Inc , Goldman Sachs Group , Crewe Advisors , Geron Company Profile , Securities Exchange Commission , Geron Corporation , Kingsview Wealth Management , Get Free Report , Exchange Commission , Trading Down , Family Office , Wealth Management , American Trust , Geron Daily ,

Geron (GERN) Q1 2024 Earnings Call Transcript

GERN earnings call for the period ending March 31, 2024. ....

Stephen Willey , John Scarlett , Tara Bancroft , Aaron Feingold , Andrew Grethlein , Kalpit Patel , Gil Blum , Faye Feller , Michelle Robertson , Gil Blum Needham , Kalpit Patelb Riley , Karin Johnson , Graig Suvannavejh Goldman Sachs , Joel Beatty , Bristol Myers Squibb , Data Monitoring Committee , Geron Corporation , Corporate Communications , Goldman Sachs , Tuuli Tsogtbaatar Stifel Financial Corp , Company Analyst , Oncology Drugs Advisory Committee , Oncologic Drugs Advisory Committee , European Commission , Investor Relations , Anil Kapur ,

Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript

Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript May 2, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.09178, expectations were $-0.1. Geron Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name […] ....

John Scarlett , Faye Feller , Michelle Robertson , Oncologic Drugs Advisory Committee , Drugs Advisory Committee , Geron Corporation , Executive Vice President , John Scarlett , Michelle Robertson , Treatment Options ,

Geron (GERN) Q4 2023 Earnings Call Transcript

GERN earnings call for the period ending December 31, 2023. ....

Faye Feller , Ethan Markowski Needham , Joel Beatty , Aaron Feingold , Aaron Finegold , Ethan Markowski , Corinne Johnson Goldman Sachs , Stephen Willey , Andrew Grethlein , Corinne Johnson , Michelle Robertson , Gil Blum , Kalpit Patelb Riley , John Scarlett , Kalpit Patel , Geron Corporation , European Commission , Company Analyst , Steve Willey Stifel Financial Corp , Goldman Sachs , Corporate Communications , Investor Relations , Anil Kapur , Motley Fool Stock Advisor , Stock Advisor , Risk Factors ,

Geron (GERN) Q4 2023 Earnings Call Transcript

GERN earnings call for the period ending December 31, 2023. ....

Faye Feller , Andrew Grethlein , Ethan Markowski , Gil Blum , Aaron Feingold , Ethan Markowski Needham , Kalpit Patel , Kalpit Patelb Riley , Joel Beatty , Michelle Robertson , John Scarlett , Corinne Johnson , Aaron Finegold , Corinne Johnson Goldman Sachs , Stephen Willey , Corporate Communications , Geron Corporation , European Commission , Company Analyst , Goldman Sachs , Steve Willey Stifel Financial Corp , Investor Relations , Anil Kapur , Risk Factors , Vice President , Chief Medical ,